Age had no effect on #betacell glucose and insulin sensitivity in antibody-positive individuals progressing to stage 3 #T1D; declining metabolic function was predictable and age independent @cevansmo @IUSweetTweets @gabiscavacini #MedTwitter https://t.co/8Nd5FosEuw 🔓

We had a wonderful holiday celebration last Friday evening! Thank you to all who joined the festivities and @HarrisonCtrArts for sharing their beautiful space.

Risk screening through TrialNet is offered at no cost to eligible individuals to evaluate their personal risk of developing type 1 diabetes. ​ The first step starts with enrolling in the Pathway to Prevention Study at https://t.co/TxC7UN5XDu  or using the link in our bio!

Congratulations to Senta for her John Hutton Rising Star Award👏👏👏Last night had the weirdest of dreams…was having a drink with John Hutton and Lelio Orci at “The Langham Tap Room”. While super happy for Senta, they were both lamenting why we don’t have more mentors like Anil!

Strong #mentorship is integral to our daily efforts! Check out the latest @IUMedSchool blog for a glimpse into what makes our @IUSweetTweets team so special. #DiabetesAwarenessMonth @EvansMolina_Lab @cevansmo @EmKSims https://t.co/UDP0HtxCUy

We're still buzzing with excitement over the good news! ICYMI: Our @IUMedSchool researchers with @T1D_TrialNet helped contribute to the first FDA-approved drug to delay the onset of #Type1Diabetes. https://t.co/zlqbVneajq

Exciting opportunity to join the new NIHR Biomedical Research Centre in Exeter as a Senior Research Technician to work with a multidisciplinary team of clinicians and scientists with expertise in diabetes and neuroscience @uniofexeHLS @Exeter_Diabetes https://t.co/izgqUYq4qs

Congratulations to @BetterCallBex on a wonderful thesis defense seminar, and congrats to @spaeth_jason on some excellent mentoring!

Happy and honored to be invited to share the stage with Dr. CR Kahn and 12 nationally identified early-career research scholars at the upcoming 2022 Rising Stars Symposium @UKYMedicine @universityofky I will be talking about #m6A, #T2D, and #betacells. Registration closes today

Way overdue but never too late I guess…during the early part of the pandemic and shutdown, everyone was struggling. As a full time single mom of a 3 and 6 yo at the time, and a full time researcher and physician, itching to see patients and also do research, I had a lot to say.

⁦⁦@john_den_⁩ kicking off his #easd2022 rising star award, amazing research on treatment of t2d, and the chair also mentioned his exceptionally good haircut @Exeter_Diabetes⁩

Please join us in thanking the co-chairs of the HIRN 2022 Annual Investigator Meeting - Drs. Holger Russ, Amelia Linnemann, Sangeeta Dhawan and Katie Coate. They provided scientific guidance, leadership and oversight in the meeting planning process. #HIRN2022

Please consider answering this survey if you are a woman scientist in #diabetes! #niddk @thesugarscience @IUSweetTweets @diabdocsk12 @jessdunnephd @bcorkey @EmKSims @Heba_T1D @DarleenSandoval @DurgaSinger #WomenInSTEM @mhill226 @jamielfelton @LinnemannLab

Congratulations to @OlhaMelnyk4 on a very well deserved abstract award for her work she will present at the upcoming HIRN meeting!

Happy to present some data of my project at 8th Annual Diabetes Symposium. I am very thankful for my mentor Dr. Erica Cai and my collaborators. @IUSweetTweets

Starting the day off strong @IUSweetTweets symposium with an exciting talk by the Dr Jane Reusch #IUCDMD2022 #diabetes #exerciseiskey

What’s up with T1D heterogeneity, you ask? @EmKSims is gonna tell us @ #IUCDMD2022

Continuing the @IUSweetTweets #IUCDMD2022 Symposium with a discussion of beta cell function during T1D pathogenesis from the talented @EmKSims

Obesity continues to be on the rise in the US, including among those with type 1 diabetes. Could the microbiome be playing a role and if so, can we modulate that? Check out our new review article, hot off the press!! https://t.co/l5nrYmfOgp

Really proud to have led the effort with #T1DI to use existing data to uncover underlying questions in #T1D. In our latest paper, we used the data to determine the optimal ages to screen with the goal to use this approach as an entry into public health screening for T1D.